Browsing Tag
Argus
2 posts
Zoetis (NYSE: ZTS) to buy VitalRADS as teleradiology partnership goes in-house
Zoetis (NYSE: ZTS) to buy VitalRADS to close its Virtual Laboratory diagnostics stack against IDEXX; deal terms expected at the 6 August Q2 call.
TBBK is back on retail radar, but can The Bancorp prove the story in Q1?
Is The Bancorp (NASDAQ: TBBK) worth watching before April 2026 earnings? Read the catalyst, valuation, risks, and retail investor roadmap now.